Diabetes Care, Vol 17, Issue 7 640-648, Copyright © 1994 by American Diabetes Association

ARTICLES

Hyperinsulinemia and macrosomia in the fetus of the diabetic mother

R Schwartz, PA Gruppuso, K Petzold, D Brambilla, V Hiilesmaa and KA Teramo
Department of Pediatrics, Brown University, Rhode Island Hospital, Providence 02903.

OBJECTIVE--To determine 1) whether macrosomia in the fetus of the diabetic mother is related to fetal hyperinsulinemia and 2) whether hyperinsulinemia and macrosomia are related to maternal metabolic control. RESEARCH DESIGN AND METHODS--Normal pregnant women (n = 95) were compared with insulin-treated pregnant women (n = 155), who were subdivided according to White's class, hypertension, and mode of delivery. All women were treated to achieve optimal metabolic control. HbA1c was determined at each visit. At delivery, umbilical plasma was analyzed for glucose, insulin antibodies, total insulin, free insulin, C-peptide, proinsulin components, and total and individual amino acids. RESULTS--Macrosomia, defined as > 2 standard deviation units (97.75%), was found in 10-27% of the diabetic groups. It was not related to maternal mass or size, but was significantly correlated with umbilical total insulin, free insulin, and C-peptide. Proinsulin components were not different among groups. Amino acids also were not different. Glycosylated hemoglobin was a weak predictor of birth weight and fetal hyperinsulinism. CONCLUSIONS--Macrosomia in the fetus of the diabetic mother remains inadequately explained. In a large population of pregnant women with strict metabolic control, macrosomia was mainly independent of glycosylated hemoglobin. Nevertheless, fetal hyperinsulinism remains the driving force for excessive fetal growth. The stimulus for fetal insulin excess in humans remains to be defined.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. E. Fineberg, T. T. Kawabata, D. Finco-Kent, R. J. Fountaine, G. L. Finch, and A. S. Krasner Immunological Responses to Exogenous Insulin Endocr. Rev., October 1, 2007; 28(6): 625 - 652. [Abstract] [Full Text] [PDF]

				V. Balaji, B. S. Madhuri, S. Ashalatha, S. Sheela, S. S, and V. Seshiah A1C in Gestational Diabetes Mellitus in Asian Indian Women Diabetes Care, July 1, 2007; 30(7): 1865 - 1867. [Full Text] [PDF]

				A. de Leiva, D. Mauricio, and R. Corcoy Diabetes-Related Autoantibodies and Gestational Diabetes Diabetes Care, July 1, 2007; 30(Supplement_2): S127 - S133. [Full Text] [PDF]

				C. W. Heilig, T. Saunders, F. C. Brosius III, K. Moley, K. Heilig, R. Baggs, L. Guo, and D. Conner Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy PNAS, December 23, 2003; 100(26): 15613 - 15618. [Abstract] [Full Text] [PDF]

				R. S. Lindsay, J. D. Walker, I. Halsall, C. N. Hales, A. A. Calder, B. A. Hamilton, and F. D. Johnstone Insulin and Insulin Propeptides at Birth in Offspring of Diabetic Mothers J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1664 - 1671. [Abstract] [Full Text] [PDF]

				R. M. Cowett The Infant of the Diabetic Mother NeoReviews, September 1, 2002; 3(9): e173 - 189. [Full Text] [PDF]

				J.G. Ray, M.J. Vermeulen, J.L. Shapiro, and A.B. Kenshole Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study QJM, July 1, 2001; 94(7): 347 - 356. [Abstract] [Full Text] [PDF]

				A. WIZNITZER, B. FURMAN, I. ZUILI, S. SHANY, E. A. REECE, and M. MAZOR Cord Leptin Level and Fetal Macrosomia Obstet. Gynecol., November 1, 2000; 96(5): 707 - 713. [Abstract] [Full Text] [PDF]

				M. F. Lopez, P. Dikkes, D. Zurakowski, L. Villa-Komaroff, and J. A. Majzoub Regulation of Hepatic Glycogen in the Insulin-Like Growth Factor II-Deficient Mouse Endocrinology, March 1, 1999; 140(3): 1442 - 1448. [Abstract] [Full Text]